Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury

European Journal of Pharmacology

Volumn 699, Issue 1-3, 2013, Pages 106-111

  Hirata, Yoichiro ^a,b   Kurobe, Hirotsugu ^a   Nishio, Chika ^a   Tanaka, Kimie ^b   Fukuda, Daiju ^a   Uematsu, Etsuko ^a   Nishimoto, Sachiko ^a   Soeki, Takeshi ^a   Harada, Nagakatsu ^a   Sakaue, Hiroshi ^a   Kitagawa, Tetsuya ^a   Shimabukuro, Michio ^a   Nakaya, Yutaka ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diabetes mellitus; Endovascular injury; Exendin 4; GLP 1; Neointimal hyperplasia

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL INJURY; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; FEMORAL ARTERY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; INSULIN TOLERANCE TEST; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; AORTA; CELL PROLIFERATION; FEMORAL ARTERY; FLUORESCENT ANTIBODY TECHNIQUE; HYPOGLYCEMIC AGENTS; INFUSION PUMPS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PEPTIDES; RATS; RECEPTORS, GLUCAGON; VASCULAR SYSTEM INJURIES; VENOMS;

EID: 84871875423     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.057     Document Type: Article

References (32)

1. M. Arakawa, T. Mita, K. Azuma, C. Ebato, H. Goto, T. Nomiyama, Y. Fujitani, T. Hirose, R. Kawamori, and H. Watada Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4 Diabetes 59 2010 1030 1037
2. K. Ban, M.H. Noyan-Ashraf, J. Hoefer, S.S. Bolz, D.J. Drucker, and M. Husain Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2008 2340 2350
3. J.M. Barragan, R.E. Rodriguez, and E. Blazquez Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats Am. J. Physiol. 266 1994 E459 466
4. E. Bojanowska, and B. Stempniak Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat Regul. Pept. 91 2000 75 81
5. P.L. Brubaker, and D.J. Drucker Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system Endocrinology 145 2004 2653 2659
6. D.J. Drucker The biology of incretin hormones Cell Metab. 3 2006 153 165
7. J. Dupre, M.T. Behme, and T.J. McDonald Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes J. Clin. Endocrinol. Metab. 89 2004 3469 3473
8. M.J. Garcia, P.M. McNamara, T. Gordon, and W.B. Kannel Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study Diabetes 23 1974 105 111
9. S.M. Gardiner, J.E. March, P.A. Kemp, and T. Bennett Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats J. Pharmacol. Exp. Ther. 316 2006 852 859
10. H. Goto, T. Nomiyama, T. Mita, E. Yasunari, K. Azuma, K. Komiya, M. Arakawa, W.L. Jin, A. Kanazawa, R. Kawamori, Y. Fujitani, T. Hirose, and H. Watada Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury Biochem. Biophys. Res. Commun. 405 2011 79 84
11. D.J. Grieve, R.S. Cassidy, and B.D. Green Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br. J. Pharmacol. 157 2009 1340 1351
12. N. Isbil-Buyukcoskun, and G. Gulec Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin Regul. Pept. 118 2004 33 38
13. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease. The Framingham study JAMA 241 1979 2035 2038
14. T.J. Kieffer, C.H. McIntosh, and R.A. Pederson Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
15. W. Kim, and J.M. Egan The role of incretins in glucose homeostasis and diabetes treatment Pharmacol. Rev. 60 2008 470 512
16. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
17. O.G. Kolterman, J.B. Buse, M.S. Fineman, E. Gaines, S. Heintz, T.A. Bicsak, K. Taylor, D. Kim, M. Aisporna, Y. Wang, and A.D. Baron Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes J. Clin. Endocrinol. Metab. 88 2003 3082 3089
18. J. Lonborg, N. Vejlstrup, H. Kelbaek, H.E. Botker, W.Y. Kim, A.B. Mathiasen, E. Jorgensen, S. Helqvist, K. Saunamaki, P. Clemmensen, L. Holmvang, L. Thuesen, L.R. Krusell, J.S. Jensen, L. Kober, M. Treiman, J.J. Holst, and T. Engstrom Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur. Heart. J 2011
19. S. Park, X. Dong, T.L. Fisher, S. Dunn, A.K. Omer, G. Weir, and M.F. White Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function J. Biol. Chem. 281 2006 1159 1168
20. G. Richter, O. Feddersen, U. Wagner, P. Barth, R. Goke, and B. Goke GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery Am. J. Physiol. 265 1993 L374 381
21. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
22. M. Sata, Y. Maejima, F. Adachi, K. Fukino, A. Saiura, S. Sugiura, T. Aoyagi, Y. Imai, H. Kurihara, K. Kimura, M. Omata, M. Makuuchi, Y. Hirata, and R. Nagai A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia J. Mol. Cell. Cardiol. 32 2000 2097 2104
23. M. Sauve, K. Ban, M.A. Momen, Y.Q. Zhou, R.M. Henkelman, M. Husain, and D.J. Drucker Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice Diabetes 59 2010 1063 1073
24. N. Sreejayan, and X. Yang Isolation and functional studies of rat aortic smooth muscle cells Methods Mol. Med. 139 2007 283 292
25. M. Stoffel, R. Espinosa 3rd, M.M. Le Beau, and G.I. Bell Human glucagon-like peptide-1 receptor gene. Localization to chromosome band 6p21 by fluorescence in situ hybridization and linkage of a highly polymorphic simple tandem repeat DNA polymorphism to other markers on chromosome 6 Diabetes 42 1993 1215 1218
26. M. Szayna, M.E. Doyle, J.A. Betkey, H.W. Holloway, R.G. Spencer, N.H. Greig, and J.M. Egan Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats Endocrinology 141 2000 1936 1941
27. K. Tanaka, M. Sata, Y. Hirata, and R. Nagai Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries Circ. Res. 93 2003 783 790
28. B. Thorens Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1 Proc. Nat. Acad. Sci. U.S.A. 89 1992 8641 8645
29. A.K. Vyas, K.C. Yang, D. Woo, A. Tzekov, A. Kovacs, P.Y. Jay, and P.W. Hruz Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy PLoS One 6 2011 e17178
30. Y. Wei, and S. Mojsov Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences FEBS Lett. 358 1995 219 224
31. A.A. Young, B.R. Gedulin, S. Bhavsar, N. Bodkin, C. Jodka, B. Hansen, and M. Denaro Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta) Diabetes 48 1999 1026 1034
32. M. Yu, C. Moreno, K.M. Hoagland, A. Dahly, K. Ditter, M. Mistry, and R.J. Roman Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats J. Hypertens. 21 2003 1125 1135